BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: Identification of four novel mutations and high-frequency occurrence of 185delAG mutation

Journal of Biosciences

Volumn 34, Issue 3, 2009, Pages 415-422

  Vaidyanathan, Kannan ^a   Lakhotia, Smita ^a   Ravishankar, H M ^a   Tabassum, Umaira ^b   Mukherjee, Geetashree ^b   Somasundaram, Kumaravel ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

BRCA1; BRCA2; Breast cancer; Cancer predisposition; CSGE; Haplotype; Mutation; PCR

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; DNA SEQUENCE; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETICS; GEOGRAPHY; HUMAN; INDIA; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENES, BRCA1; GENES, BRCA2; GEOGRAPHY; GERM-LINE MUTATION; HUMANS; INDIA; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; OVARIAN NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 73449143225     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-009-0048-9     Document Type: Article

References (41)

1. Antoniou A, Pharoah P D, Narod S, Risch H A, Eyfjord J E, Hopper J L, Loman N, Olsson H, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies; Am. J. Hum. Genet. 72 1117-1130
2. Brose M S, Rebbeck T R, Calzone K A, Stopfer J E, Nathanson K L and Weber B L 2002 Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program; J. Natl. Cancer Inst. 94 1365-1372
3. Easton D F, Bishop D T, Ford D and Crockford G P 1993 Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium; Am. J. Hum. Genet. 52 678-701
4. Emery J, Lucassen A and Murphy M 2001 Common hereditary cancers and implications for primary care; Lancet 358 56-63
5. Ganguly A, Leahy K, Marshall A M, Dhulipala R, Godmilow L and Ganguly T 1997 Genetic testing for breast cancer suscept-ibility: frequency of BRCA1 and BRCA2 mutations; Genet. Test. 1 85-90
6. Ganguly A, Rock M J and Prockop D J 1993 Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes; Proc. Natl. Acad. Sci. USA 90 10325-10329
7. Gayther S A, Russell P, Harrington P, Antoniou A C, Easton D F and Ponder B A 1999 The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes; Am. J. Hum. Genet. 65 1021-1029
8. Grzybowska E, Siemińska M, Zientek H, Kalinowska E, Michalska J, Utracka-Hutka B, Rogozińska-Szczepka J and Kaźmierczak-Maciejewska M 2002 Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population; Acta Biochim. Pol. 49 351-356
9. Güran S, Ozet A, Dede M, Gille J J and Yenen M C 2005 Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis; Cancer Genet. Cytogenet. 160 164-168
10. Hall J M, Lee M K, Newman B, Morrow J E, Anderson L A, Huey B and King M C 1990 Linkage of early-onset familial breast cancer to chromosome 17q21; Science 250 1684-1689
11. Hedau S, Jain N, Husain S A, Mandal A K, Ray G, Shahid M, Kant R, Gupta V, Shukla N K, Deo S S and Das B C 2004 Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India; Breast Cancer Res. Treat. 88 177-186
12. Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M and Noguchi S 2001 Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families; Int. J. Cancer 91 83-98
13. Indian Council of Medical Research National Cancer Registry Programme (NCRP) 2001 Consolidated report of population based cancer registries, 1990-1996 Available at: http://icmr.nic.in/ncrp/ncrp-p/cancer-p-based.htm
14. Indian Council of Medical Research National Cancer Registry Programme (NCRP) 2006 Consolidated report of population based cancer registries, 2001-2004 Available at: http://icmr.nic.in/ncrp/report-pop-2001-04/cancer-p-based.htm
15. King M C, Marks J H and Mandell J B 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2; Science 302 643-646
16. Krainer M, Silva-Arrieta S, FitzGerald M G, Shimada A, Ishioka C, Kanamaru R, MacDonald D J, Unsal H, et al. 1997 Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer; N. Engl. J. Med. 336 1416-1421
17. Kumar B V, Lakhotia S, Ankathil R, Madhavan J, Jayaprakash P G, Nair M K and Somasundaram K 2002 Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families; Cancer Biol. Ther. 1 18-21
18. Lakhotia S and Somasundaram K 2003 Conformation-sensitive gel electrophoresis for detecting BRCA1 mutations; Methods Mol. Biol. 223 403-412
19. Levy-Lahad E and Friedman E 2007 Cancer risks among BRCA1 and BRCA2 mutation carriers; B r. J. Cancer 96 11-15
20. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber B L, et al. 1997 Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families; Am. J. Hum. Genet. 60 1059-1067
21. Liebens F P, Carly B, Pastijn A and Rozenberg S 2007 Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006; Eur. J. Cancer 43 238-257
22. Mehdipour P, Hosseini-Asl S, Savabi-E A, Habibi L, Alvandi E and Atri M 2006 Low frequency of 185delAG founder mutation of BRCA1 gene in Iranian breast cancer patients; J. Cancer Molecules 2 123-127
23. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1; Science 266 66-71
24. Mullineaux L G, Castellano T M, Shaw J, Axell L, Wood M E, Diab S, Klein C, Sitarik M, et al. 2003 Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado; Cancer 98 597-602
25. Narod S A and Foulkes W D 2004 BRCA1 and BRCA2: 1994 and beyond; Nat. Rev. Cancer 4 665-676
26. Parkin D M W S, Ferlay J, Teppo L and Thomas D B (eds) 2002 Cancer incidence in five continents, volume VIII (Lyon, France: IARC)
27. Phelan C M, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D and Narod S A 2002 A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families; Hum. Mutat. 20 352-357
28. Rajkumar T, Soumittra N, Nancy N K, Swaminathan R, Sridevi V and Shanta V 2003 BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India; Asian Pac. J. Cancer Prev. 4 203-208
29. Rashid M U, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori A R, Seidel-Renkert A, et al. 2006 Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients; Int. J. Cancer 119 2832-2839
30. Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil R S, Chintamani C, Aggarwal A K, et al. 2006 Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India; BMC Med. Genet. 7 75
31. Saxena S, Szabo C I, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar D E and Bhatanager D 2002 BRCA1 and BRCA2 in Indian breast cancer patients; Hum. Mutat. 20 473-474
32. Shih H A, Couch F J, Nathanson K L, Blackwood M A, Rebbeck T R, Armstrong K A, Calzone K, Stopfer J, et al. 2002 BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic; J. Clin. Oncol. 20 994-999
33. Somasundaram K 2003 Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair - perhaps through transcription; J. Cell Biochem. 88 1084-1091
34. Struewing J P, Abeliovich D, Peretz T, Avishai N, Kaback M M, Collins F S and Brody L C 1995 The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals; Nat. Genet. 11 198-200
35. Valarmathi M T, Agarwal A, Deo S S, Shukla N K and Das S N 2003 BRCA1 germline mutations in Indian familial breast cancer; Hum. Mutat. 21 98-99
36. Valarmathi M T, Sawhney M, Deo S S, Shukla N K and Das S N 2004 Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families; Hum. Mutat. 23 205
37. Weitzel J N, Lagos V, Blazer K R, Nelson R, Ricker C, Herzog J, McGuire C and Neuhausen S 2005 Prevalence of BRCA mutations and founder effect in high-risk Hispanic families; Cancer Epidemiol. Biomarkers Prev. 14 1666-1671
38. Williams C J, Rock M, Considine E, McCarron S, Gow P, Ladda R, McLain D, Michels V M, et al. 1995 Three new point mutations in type II procollagen (COL2A1) and identification of a fourth family with the COL2A1 Arg519→Cys base substitution using conformation sensitive gel electrophoresis; Hum. Mol. Genet. 4 309-312
39. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G 1995 Identification of the breast cancer susceptibility gene BRCA2; Nature (London) 378 789-792
40. Wooster R and Weber B L 2003 Breast and ovarian cancer; N. Engl. J. Med. 348 2339-2347
41. Zhi X, Szabo C, Chopin S, Suter N, Wang Q S, Ostrander E A, Sinilnikova O M, Lenoir G M, Goldgar D and Shi Y R 2002 BRCA1 and BRCA2 sequence variants in Chinese breast cancer families; Hum. Mutat. 20 474